ns 1619 has been researched along with Apoplexy in 1 studies
NS 1619: structure given in first source
NS 1619 : A member of the class of benzimidazoles that is 1,3-dihydro-2H-benzimidazol-2-one in which the hydrogens at positions 1 and 5 are replaced are replaced by 2-hydroxy-5-(trifluoromethyl)phenyl and trifluoromethyl groups, respectively. It is an opener/activator of the large-conductance calcium-activated potassium channel (Bkca).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Romine, JL | 1 |
| Martin, SW | 1 |
| Meanwell, NA | 1 |
| Gribkoff, VK | 1 |
| Boissard, CG | 1 |
| Dworetzky, SI | 1 |
| Natale, J | 1 |
| Moon, S | 1 |
| Ortiz, A | 1 |
| Yeleswaram, S | 1 |
| Pajor, L | 1 |
| Gao, Q | 1 |
| Starrett, JE | 1 |
1 other study available for ns 1619 and Apoplexy
| Article | Year |
|---|---|
3-[(5-Chloro-2-hydroxyphenyl)methyl]-5-[4-(trifluoromethyl)phenyl ]-1,3,4-oxadiazol-2(3H)-one, BMS-191011: opener of large-conductance Ca(2+)-activated potassium (maxi-K) channels, identification, solubility, and SAR.
Topics: Animals; Brain; Crystallography, X-Ray; Female; In Vitro Techniques; Ion Channel Gating; Large-Condu | 2007 |